Koers Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Aandelen
IL0006290147
Farmaceutische producten
Omzet 2024 * | 15,92 mld. 59,17 mld. 14,78 mld. | Omzet 2025 * | 16,49 mld. 61,29 mld. 15,31 mld. | Marktkapitalisatie | 18,41 mld. 68,41 mld. 17,09 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 820 mln. 3,05 mld. 761 mln. | Nettowinst (verlies) 2025 * | 1,39 mld. 5,16 mld. 1,29 mld. | EV/omzet 2024 * | 2,09 x |
Nettoschuld 2024 * | 14,93 mld. 55,48 mld. 13,86 mld. | Nettoschuld 2025 * | 12,41 mld. 46,12 mld. 11,52 mld. | EV/omzet 2025 * | 1,87 x |
K/w-verhouding 2024 * |
17,3
x | K/w-verhouding 2025 * |
12
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 89,71% |
Recentste transcriptie over Teva Pharmaceutical Industries Limited
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01-01-23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22-12-19 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01-09-15 |
Janet Vergis
BRD | Director/Board Member | 59 | 09-06-20 |
Sol Barer
CHM | Chairman | 76 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+30,38% | 684 mld. | |
+26,51% | 568 mld. | |
-4,36% | 361 mld. | |
+19,30% | 329 mld. | |
+3,73% | 284 mld. | |
+16,70% | 240 mld. | |
+8,78% | 208 mld. | |
-7,93% | 200 mld. | |
+7,68% | 166 mld. |